Hage, C., Giese, N., Giese, T., Schönsiegel, F., Nwaeburu, C. C., & Herr, I. (2013). The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Cell death & disease, 4(5), . https://doi.org/10.1038/cddis.2013.158
Chicago-Zitierstil (17. Ausg.)Hage, Carina, Nathalia Giese, Thomas Giese, Frank Schönsiegel, Clifford C. Nwaeburu, und Ingrid Herr. "The Novel C-Met Inhibitor Cabozantinib Overcomes Gemcitabine Resistance and Stem Cell Signaling in Pancreatic Cancer." Cell Death & Disease 4, no. 5 (2013). https://doi.org/10.1038/cddis.2013.158.
MLA-Zitierstil (9. Ausg.)Hage, Carina, et al. "The Novel C-Met Inhibitor Cabozantinib Overcomes Gemcitabine Resistance and Stem Cell Signaling in Pancreatic Cancer." Cell Death & Disease, vol. 4, no. 5, 2013, https://doi.org/10.1038/cddis.2013.158.